Journal Articles
Featured Topics
Lead story
Other featured articles
-
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients
Schaeffer experts estimate the primary care prevalence of medical cannabis use according to confidential patient survey and to compare the prevalence of medical cannabis use documented in the EHR with patient report.
Posted in -
Trends in the Use of Cannabis Products in Canada and the USA, 2018 – 2020: Findings From the International Cannabis Policy Study
There is little information on consumption patterns across the diverse range of cannabis product types. This paper examines trends in consumption patterns in Canada and the United States (US) between 2018-2020.
Posted in -
The Eldercare Facility Ordinance of Los Angeles: A Synthetic Control Analysis of Residential Care Development and Growth
Using California State Department of Social Services residential care and census place data, this study compares the pre and post effect of the ordinance on the number of large residential care facilities developed in Los Angeles with a comparison group using synthetic control analysis.
Posted in -
Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers
Schaeffer Center experts propose two different types of payment models applicable to disease-modifying therapies in Alzheimer’s disease, and suggest four strategies to overcome challenges in their implementation.
Posted in
ADDITIONAL JOURNAL ARTICLES
-
Use of Prescription Medications with Cardiovascular Adverse Effects Among Older Adults in the United States
Schaeffer experts examined the association between the concurrent use of prescription medications with known risk of a major adverse cardiovascular event (MACE) (“MACE medications”) and the risk of such events among older adults.
Categorized in -
Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law
A new study by experts at the USC Schaeffer Center for Health Policy and Economics and Kaiser Permanente finds Naloxone prescriptions increased while opioid prescriptions decreased.
Categorized in -
Messages in Prescription Drug Advertising for Four Chronic Diseases, 2003-2016: A Content Analysis
Examining the frequency and content of messages related to pharmacological and evidence-based, non-pharmaceutical treatments in direct-to-consumer advertising (DTCA) for prescription drugs treating four chronic diseases in the United States.
Categorized in -
Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis
This study aimed to assess the cost-effectiveness of fibrosis-based direct-acting antiviral treatment policies for patients with chronic hepatitis C virus at the Kaiser Permanente Mid-Atlantic States health system.
Categorized in -
Impact of Cannabis Legalization on Healthcare Utilization for Psychosis and Schizophrenia in Colorado
Using administrative data from Colorado Hospital Association (CHA) on county-level quarterly ED visits between January 1, 2013, and December 31, 2018, Schaeffer experts applied a difference-in-difference analysis to examine how new exposure to recreational cannabis dispensaries after 2014 differentially influenced the rate of ED visits for psychosis and schizophrenia, comparing counties with no prior medical cannabis dispensary exposure to counties with low or high medical dispensary exposure.
Categorized in -
Quality of Survey Responses at Older Ages Predicts Cognitive Decline and Mortality Risk
It is widely recognized that survey satisficing, inattentive, or careless responding in questionnaires reduces the quality of self-report data.
Categorized in